VAERS 2047497
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN206
- Staat
- TX
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 31.03.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 280,0
- Dosis
- 1
- Route/Site
- - / -
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/10/2021 and 3/31/201. Presented to ED with complaints of weakness, diarrhea, and altered mental status. Admitted for hepatic encephalopathy and COVID-19 infection. Treated with dexamethasone, remdesivir, antibiotics, ascorbic acid, zinc, vitamin D, paralytics, and pressors. Developed pulmonary edema, respiratory status decompensated requiring mechanical ventilation with proning. On 1/10/2022, patient was made DNAR/COT and hemodialysis was initiated. On 1/11/2022, the patient went in to PEA arrest and expired..
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- 1/5/2022: COVID positive; 1/5/2022: Chest X-ray revealed bilateral lung infiltrates
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ankylosing spondylitis, aortic valve stenosis, cardiomegaly, chronic hepatitis C, diabetes, dyslipidemia, sleep apnea, portal hypertension, esophageal varices, liver cirrhosis, hypertension, peripheral vascular disease, allergies, cardiomegaly, Hepatic encephalopathy, Iron deficiency anemia, depression, Nonalcoholic steatohepatitis, peripheral neuropathy, restless leg syndrome
- Andere Medikamente
- ascorbic acid 1,000 mg Oral Daily, aspirin 81 mg Oral Daily, bethanechol chloride 25 mg Oral 3 times daily, bumetanide 2 mg 2 (two) times daily 4 mg in the am, 2mg in the pm., calcium carbonate/vitamin D3 500 mg-5 mcg (200 unit) 1 tablet Or
- Allergien
- No known allergies
- Vorherige Impfungen
- -
